Skip to content
10-K

Annual Report

BIODESIX INC BDSX

0000950170-25-030835

← back to feed
Filed
Mar 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 24, 2025 145.98M sh
Long Term Debt FY 2024 · Dec 31, 2024 $40.03M
Shares Diluted FY 2024 · Dec 31, 2023 82.11M sh
Capex FY 2024 · Dec 31, 2023 $22.92M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$22.87M
Cash And Equivalents FY 2024 · Dec 31, 2023 $26.28M
Current Liabilities FY 2024 · Dec 31, 2023 $33.42M
Total Liabilities FY 2024 · Dec 31, 2023 $94.52M
Current Assets FY 2024 · Dec 31, 2023 $39.68M
Total Assets FY 2024 · Dec 31, 2023 $99.1M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.64
Eps Basic FY 2024 · Dec 31, 2023 −$0.64
Sga Expense FY 2024 · Dec 31, 2023 $67.39M
Rd Expense FY 2024 · Dec 31, 2023 $9.99M
Net Income FY 2024 · Dec 31, 2023 −$52.15M
Operating Income FY 2024 · Dec 31, 2023 −$41.34M
Revenue FY 2024 · Dec 31, 2023 $49.09M
Stockholders Equity FY 2024 · Dec 31, 2022 $20.61M